Aurora C Kinase Inhibitors:阻害薬のグローバル市場2014(薬開発、治験動向)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIMR2014127)
◆英語タイトル:Aurora C Kinase Inhibitors -Pipeline Insights, 2014
◆発行会社/調査会社:DelveInsight
◆商品コード:DIMR2014127
◆発行日:2014年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:25以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥141,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Aurora C Kinase Inhibitors:阻害薬のグローバル市場2014(薬開発、治験動向)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

DelveInsight’s,“Aurora C Kinase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Aurora C Kinase Inhibitors. This report provides information on the therapeutic development based on the Aurora C Kinase Inhibitors dealing with mechanism of action, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated mechanism of action.


• The report provides a snapshot of the global therapeutic landscape of Aurora C Kinase Inhibitors
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Aurora C Kinase Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Aurora C Kinase Inhibitors and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

• Complete MOA intelligence and complete understanding over therapeutics development for Aurora C Kinase Inhibitors
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
• Devise corrective measures for pipeline projects by understanding Aurora C Kinase Inhibitors pipeline depth and focus of Indication therapeutics
• Developing strategic initiatives to support your drug development activities.
• Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
• Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
• Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

*** レポート目次(コンテンツ)***

• Aurora C Kinase Inhibitors Overview
• Aurora C Kinase Inhibitors Disease Associated
• Aurora C Kinase Inhibitors Pipeline Therapeutics
• Aurora C Kinase Inhibitors Therapeutics under Development by Companies
• Aurora C Kinase Inhibitors Late Stage Products (Filed and Phase III)
• Comparative Analysis
• Aurora C Kinase Inhibitors Mid Clinical Stage Products (Phase II)
• Comparative Analysis
• Aurora C Kinase Inhibitors Early Clinical Stage Products (Phase I and IND Filed)
• Comparative Analysis
• Aurora C Kinase Inhibitors Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Aurora C Kinase Inhibitors – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Aurora C Kinase Inhibitors – Discontinued Products
• Aurora C Kinase Inhibitors – Dormant Products
• Companies Involved in Therapeutics Development for Aurora C Kinase Inhibitors
• Appendix
• Methodology
• Contact Us
• Disclaimer

• Number of Products under Development for Aurora C Kinase Inhibitors by Therapy Area, 2014
• Number of Products under Development for Aurora C Kinase Inhibitors, 2014
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
• Drug Candidates Profiles
• Aurora C Kinase Inhibitors Assessment by Monotherapy Products
• Aurora C Kinase Inhibitors Assessment by Combination Products
• Aurora C Kinase Inhibitors Assessment by Route of Administration
• Aurora C Kinase Inhibitors Assessment by Stage and Route of Administration
• Aurora C Kinase Inhibitors Assessment by Molecule Type
• Aurora C Kinase Inhibitors Assessment by Stage and Molecule Type
• Aurora C Kinase Inhibitors Therapeutics – Discontinued Products
• Aurora C Kinase Inhibitors Therapeutics – Dormant Products
• Products under Development by Companies, 2014

• Number of Products under Development for Aurora C Kinase Inhibitors by Therapy Area, 2014
• Number of Products under Development for Aurora C Kinase Inhibitors, 2014
• Late Clinical Stage Products (Filed and Phase III), 2014
• Mid Clinical Stage Products (Phase II), 2014
• Early Clinical Stage Products (Phase I and IND Filed), 2014
• Discovery and Pre-Clinical Stage Products, 2014
• Aurora C Kinase Inhibitors Assessment by Monotherapy Products
• Aurora C Kinase Inhibitors Assessment by Combination Products
• Aurora C Kinase Inhibitors Assessment by Route of Administration
• Aurora C Kinase Inhibitors Assessment by Stage and Route of Administration
• Aurora C Kinase Inhibitors Assessment by Molecule Type
• Aurora C Kinase Inhibitors Assessment by Stage and Molecule Type

*** レポートのキーワード ***

薬剤、医薬品、製薬企業、試験、作用機序(MOA)、パイプライン、開発

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • オクタブロモビフェニルの世界市場2018
    The Global Octabromobiphenyl (CAS 27858-07-7) Industry 2018 Market Research Report is a professional and in-depth study on the current state of the Octabromobiphenyl industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and indus …
  • 世界及び中国の3-ヒドロキシキノリン(3-キノリノール)市場2017
    The 'Global and Chinese 3-Hydroxyquinoline (3-Quinolinol) Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global 3-Hydroxyquinoline (3-Quinolinol) industry with a focus on the Chinese market. The report provides key statistics on the marke …
  • 世界及び中国のサリチル酸市場2015
    The 'Global and Chinese Salicylic acid Industry, 2010-2020 Market Research Report' is a professional and in-depth study on the current state of the global Salicylic acid industry with a focus on the Chinese market. The report provides key statistics on the market status of the Salicylic acid manufac …
  • 世界の自動車電子制御ブレーキシステム市場2017
    Automotive Electronic Braking Systems Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries …
  • イソプロピルフェニルホスフェートの世界市場2018
    Isopropylphenyl phosphate (CAS 68937-41-7) Market Research Report 2018 aims at providing comprehensive data on Isopropylphenyl phosphate market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Isopropylphenyl phosphate description, covers its application …
  • Copaxone (Multiple Sclerosis):市場予測と分析(~2022)
    Copaxone (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Copaxone (Multiple Sclerosis) - Forecast and Market Analysis to 2022”. Multiple sclerosis (MS) is a chronic, inflammatory neurological disorder characteri …
  • Hammerfest Strom AS(代替エネルギー分野):企業M&A動向
    Summary Hammerfest Strom AS (Hammerfest Strom) is a tidal power generation company. The company manufactures and distributes tidal turbines to convert the kinetic energy in tidal water to electricity. It delivers turn-key tidal power plants consisting of several tidal turbines connected together and …
  • BTS伝送回線用RFコネクタの世界市場:販売動向2017
    Notes:Sales, means the sales volume of BTS Transmission Line RF Connector Revenue, means the sales value of BTS Transmission Line RF Connector This report studies sales (consumption) of BTS Transmission Line RF Connector in Global market, especially in United States, China, Europe and Japan, focuses …
  • 体重減量及び体重管理ダイエットの北米市場
    KEY FINDINGSThe weight loss and weight management diet market in North America generated a revenue of $5851 million in 2016, thus capturing the largest share in the global markets. The market is expected to grow at CAGR of 2.12% during the forecast period of 2017-2025 and generate $71025 million by …
  • 世界の配電設備市場2017
    Notes:Sales, means the sales volume of Electrical Equipment for the Power Distribution Revenue, means the sales value of Electrical Equipment for the Power Distribution This report studies sales (consumption) of Electrical Equipment for the Power Distribution in Global market, especially in United S …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIMR2014127 )"Aurora C Kinase Inhibitors:阻害薬のグローバル市場2014(薬開発、治験動向)" (英文:Aurora C Kinase Inhibitors -Pipeline Insights, 2014)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。